Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals Inc (NQ: MDGL )

347.93 +0.48 (+0.14%)
Streaming Delayed Price Updated: 3:52 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 324,498
Open 347.34
Bid (Size) 346.93 (11)
Ask (Size) 347.99 (6)
Prev. Close 347.45
Today's Range 340.43 - 351.81
52wk Range 168.25 - 368.29
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 3 Health Care Stocks That May Dip This Month
Via Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Via The Motley Fool

Performance

YTD
+53.37%
+53.37%
1 Month
+65.15%
+65.15%
3 Month
+36.02%
+36.02%
6 Month
+55.82%
+55.82%
1 Year
+76.35%
+76.35%

More News

Read More
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
Via The Motley Fool
MDGL: A Promising Play In The Weight Loss Drug Space
Via Talk Markets
Topics Stocks / Equities
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
Via The Motley Fool
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Via Benzinga
Earnings Preview For Madrigal Pharmaceuticals
Via Benzinga
Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Is Madrigal Pharmaceuticals Stock a Buy?
Via The Motley Fool
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
Via The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
Is Madrigal Pharmaceuticals a Millionaire Maker?
Via The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
Via The Motley Fool
The Best Biotech Stock to Invest $1,000 in Right Now
Via The Motley Fool
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
Via Investor's Business Daily
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Via The Motley Fool
Where Will Madrigal Pharmaceuticals Be in 3 Years?
Via The Motley Fool
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
Via The Motley Fool
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.